Jun 14 |
Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit
|
May 22 |
Insider Buyers At Generation Bio Sitting On US$1.1m Profit
|
May 13 |
Generation Bio GAAP EPS of -$1.12 misses by $0.71, revenue of $4.1M beats by $2.73M
|
May 13 |
Generation Bio Co. (GBIO) Reports Q1 Loss, Tops Revenue Estimates
|
May 13 |
Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results
|
May 9 |
Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting
|
Apr 22 |
Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting
|
Apr 2 |
Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference
|
Mar 8 |
Generation Bio Co Reports Full Year and Q4 2023 Financial Outcomes
|
Mar 7 |
Generation Bio GAAP EPS of -$0.53
|